W. Roa

R. Löbenberg, W. Finlay, W. Roa, 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Optimization of a two-step desolvation method for preparing gelatin nanoparticles and cell uptake studies in 143B osteosarcoma cancer cells.

R. Löbenberg, S. McQuarrie, Yuan Huang, 2006, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

Development of Inhalable Nanoparticles

Jeffrey O. H. Sham, R. Löbenberg, W. Finlay, 2004, 2004 International Conference on MEMS, NANO and Smart Systems (ICMENS'04).

Farnesol for aerosol inhalation: nebulization and activity against human lung cancer cells.

W. Finlay, Zhao-quan Wang, W. Roa, 2003, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

Interaction of M2 macrophages with hepatocellular carcinoma co-culture system in the presence of doxorubicin-loaded nanoparticles

R. Löbenberg, A. Siraki, S. Elahi, 2022, Journal of Drug Delivery Science and Technology.

Size dependent interactions of nanoparticles with lung surfactant model systems and the significant impact on surface potential.

R. Löbenberg, E. Prenner, S. Azarmi, 2008, Journal of nanoscience and nanotechnology.

Use of mucolytics to enhance magnetic particle retention at a model airway surface

Alidad Amirfazli, Wilson Roa, Javed Ally, 2008 .

Factors affecting magnetic retention of particles in the upper airways: an in vitro and ex vivo study.

A. Amirfazli, J. Ally, W. Roa, 2006, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

Magnetic targeting of aerosol particles for cancer therapy

Mir Behrad Khamesee, Alidad Amirfazli, Wilson Roa, 2005 .

Secondary cytotoxicity mediated by alveolar macrophages: a contribution to the total efficacy of nanoparticles in lung cancer therapy?

Raimar Löbenberg, Anwar Anwar-Mohamed, R. Löbenberg, 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Inflammation Caused by Nanosized Delivery Systems: Is There a Benefit?

R. Löbenberg, M. Sarfraz, N. Bou-Chacra, 2016, Molecular pharmaceutics.

Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles.

R. Löbenberg, W. Finlay, Zhao-quan Wang, 2006, International journal of pharmaceutics.

Distribution of effervescent inhalable nanoparticles after pulmonary delivery: an in vivo study.

R. Löbenberg, W. Finlay, M. Sarfraz, 2012, Therapeutic delivery.

Hyaluronic Acid-Tocopherol Succinate-Based Self-Assembling Micelles for Targeted Delivery of Rifampicin to Alveolar Macrophages.

R. Löbenberg, M. Sarfraz, S. Clas, 2015, Journal of biomedical nanotechnology.

Pharmacokinetic and toxicological evaluation of multi-functional thiol-6-fluoro-6-deoxy-d-glucose gold nanoparticles in vivo

Yeping Xiong, W. Roa, B. Kong, 2012, Nanotechnology.

Targeted delivery of nanoparticles for the treatment of lung diseases.

R. Löbenberg, S. Azarmi, W. Roa, 2008, Advanced drug delivery reviews.

Pulmonary delivery of inhalable nanoparticles: dry powder inhalers.

R. Löbenberg, W. Finlay, M. Sarfraz, 2011, Therapeutic delivery.

Biophysical Investigation of Nanoparticle Interactions with Lung Surfactant Model Systems

R. Löbenberg, D. Stuart, E. Prenner, 2006 .

Determination of contact angle of microspheres by microscopy methods

Reza Mohammadi, Warren H. Finlay, Wilson H.-Y. Roa, 2003, Proceedings International Conference on MEMS, NANO and Smart Systems.